|
|
|
Insider
Information: |
Cook Jennifer E. |
Relationship: |
Director |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
35,536 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,392,585 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
35,536 |
|
|
Total
Value |
$1,392,585 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Denali Therapeutics Inc. |
DNLI |
Director |
2024-05-31 |
21,496 |
|
0 |
Premium* |
|
Bridgebio Pharma, Inc. |
BBIO |
Director |
2021-11-16 |
7,152 |
2020-11-16 |
0 |
Premium* |
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2023-12-04 |
6,888 |
2021-02-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BBIO |
Bridgebio Pharma, Inc. |
Director |
|
2020-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,576 |
3,576 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
2,590 |
2,590 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2021-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,253 |
3,253 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,074 |
5,327 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2021-07-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,246 |
4,836 |
0 |
- |
|
BBIO |
Bridgebio Pharma, Inc. |
Director |
|
2021-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,576 |
7,152 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2022-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,986 |
11,313 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,561 |
6,980 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,216 |
15,529 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2023-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
3,075 |
8,546 |
0 |
- |
|
DNLI |
Denali Therapeutics Inc. |
Director |
|
2024-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
5,967 |
21,496 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2023-12-04 |
4 |
S |
$119.27 |
$49,736 |
D/D |
(417) |
6,888 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2021-12-02 |
4 |
S |
$121.30 |
$50,582 |
D/D |
(417) |
4,419 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2022-12-02 |
4 |
S |
$154.68 |
$64,966 |
D/D |
(420) |
5,471 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2022-08-08 |
4 |
S |
$152.32 |
$165,879 |
D/D |
(1,089) |
5,891 |
0 |
- |
|
JAZZ |
Jazz Pharmaceuticals Inc |
Director |
|
2023-08-14 |
4 |
S |
$138.16 |
$171,454 |
D/D |
(1,241) |
7,305 |
0 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|